---
title: Advances in Bioanalytical Tools for the Characterization of In-Process Viral Samples
description: In this webcast, learn how BLI technology can be used for the development of analytical tools for the quantification of viral particles used in vaccines.
---

[![BPI Media_Logo 2_Color 1](https://bpi.bioprocessintl.com/hs-fs/hubfs/BPI%20Media_Logo%202_Color%201.png?width=350&height=161&name=BPI%20Media_Logo%202_Color%201.png)](https://bioprocessintl.com/)

#                                          ![New-ATE-Logo2019 (1)](https://bpi.bioprocessintl.com/hs-fs/hubfs/New-ATE-Logo2019%20(1).png?width=700&name=New-ATE-Logo2019%20(1).png)

# Advances in Bioanalytical Tools for the

# Characterization of In-Process Viral Samples

|  |
| --- |

## Presenter:

****![](https://bpi.bioprocessintl.com/hs-fs/hubfs/4-4-2023-Sartorius-Octet-ATE-Speaker-HS-Cropped.jpg?width=168&height=237&name=4-4-2023-Sartorius-Octet-ATE-Speaker-HS-Cropped.jpg)****

**Sofia B. Carvalho, PhD**

*Senior Research Associate,*

iBET

 

Sofia Carvalho is a senior research associate at the Animal Cell Technology Unit of iBET. She has a background in biochemistry, and received her doctoral degree in biotechnology from ITQB-NOVA in 2018. Her PhD research was in downstream processing strategies for Influenza VLPs and the development of analytical tools for bioprocess optimization and product characterization. Sofia did part of her doctoral studies at the Max Planck Institute for the Dynamics of Complex Technical Systems (Germany) and Pall Life Sciences (United Kingdom).

 

In early 2018, she joined Genibet Biopharmaceuticals to work as a project manager on viral process development and CGMP manufacturing. Sofia's research interests are mainly related to downstream processing and analytical tools for biopharmaceuticals, covering protein, and virus and VLP production (from cell expansion to product purification). Currently, she's focused on the impact of operating variables on process performance and product quality.

## About this event:

#### Date: April 4, 2023

#### Time: 11 am ET | 8 am PT | 5 pm CEST

#### Duration: 60 minutes

The expanding landscape of viruses and virus-like particles (VLPs) holds great promise for the development of safe and effective vaccines for a wide range of diseases. To keep up with the bioprocess progress requirements and growing regulatory constraints, it is critical to improve high-throughput in-process product quality control and vaccine manufacturing monitoring. There is a current need for novel and robust analytical tools in this area.

 

iBET has a long track record in virus bioprocess development and has been focused on establishing strong competencies in bioanalytics.

 

In this webcast, we will demonstrate how biolayer interferometry (BLI) technology applied on an Octet® platform can be used for the development of analytical tools for the quantification of viral particles used in vaccines. We will present two strategies for quantification of in-process samples at all stages of the bioprocess, a Rotavirus vaccine, and an Influenza VLPs vaccine candidate.

 

Key Takeaways:

- Understand why advanced and robust bioanalytics for viral-based vaccine development and process monitoring are needed.
- Assess how BLI technology can be used to quantify in-process viral samples, while being compatible with bioprocess development timelines constraints, reducing resources and associated costs.
- Learn about the development of a cell- and label-free method, suitable for real process samples, achieving titers comparable with gold standard methods.

-  

-  

©2015 BioProcess International All Rights reserved